The first human trials of an Ebola vaccine will start next week in the United States to see if it is safe in people before it can be made available, scientists said Thursday. There is no vaccine on the market against Ebola, and global attempts to get one ready are being fast-tracked as West Africa struggles with an accelerating outbreak of the hemorrhagic virus. The first US phase 1 trial has enrolled three volunteers so far, and begins next week at the National Institutes of Health Clinical Center. It involves a product made by Glaxo Smith Kline and US government scientists, and is being referred to as the NIAID/GSK Ebola vaccine candidate.
via Health News Headlines - Yahoo News http://ift.tt/1C70KGF
No comments:
Post a Comment